Novozymes results: Acrylamide-removing, trans fat reduction and low-lactose solutions drive F&B grow
date:Oct 26, 2018
der Holk Nielsen, President CEO comments.

Despite recent challenging markets in the Middle-East, we maintain our 4-6 percent organic revenue growth guidance, albeit with the likelihood that we will close the year toward the lower part of the range.

On our innovation efforts, we further demonstrate our strong pipeline and ability to commercialize game-changing solutions with the third-quarter launch of Balancius for animal feed, he adds.

Profit outlook
The reported EBIT margin in the first ni
8/10 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
07/09 20:17